Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Laheru

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Cureus|February 28, 2022
Calciphylaxis Cutis Associated With Fibroblast Growth Factor Receptor (FGFR) Inhibitor Therapy: A New ChallengePaige Griffith, Jaroslaw Jedrych, Joel Sunshine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2017
Strategies for Increasing Pancreatic Tumor ImmunogenicityBurles A Johnson, Mark Yarchoan, Valerie Lee, et al.
Nature Reviews. Cancer|August 25, 2017
Targeting neoantigens to augment antitumour immunityMark Yarchoan, Burles A Johnson, Eric R Lutz, et al.
Nature Reviews. Cancer|February 25, 2017
Targeting neoantigens to augment antitumour immunityMark Yarchoan, Burles A Johnson, Eric R Lutz, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 19, 2021
Projected 30- day out-of-pocket costs and total spending on pancreatic enzyme replacement therapy under Medicare Part DArjun Gupta, Naveen Premnath, Ramy Sedhom, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2020
Intraductal pancreatic cancer is less responsive than cancer in the stroma to neoadjuvant chemotherapyKohei Fujikura, Danielle Hutchings, Alicia M Braxton, et al.
CA: a Cancer Journal for Clinicians|July 17, 2013
Recent progress in pancreatic cancerChristopher L Wolfgang, Joseph M Herman, Daniel A Laheru, et al.
Nuklearmedizin. Nuclear Medicine|April 17, 2025
Pancreatic Neuroendocrine Tumor incidentally found on 68Ga-PSMA PET/CTRodrigo Luna, Daniel A Laheru, Eun Ji Shin, et al.
Pancreas|December 28, 2020
Survival Outcomes of Adjuvant Chemotherapy Combined With Radiation Versus Chemotherapy Alone After Pancreatectomy for Distal Pancreatic Adenocarcinoma: A Single-Institution ExperienceBhavina Batukbhai, Joseph M Herman, Marianna Zahurak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression AnalysisArsen Osipov, Su Jin Lim, Aleksandra Popovic, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Cureus|February 28, 2022
Calciphylaxis Cutis Associated With Fibroblast Growth Factor Receptor (FGFR) Inhibitor Therapy: A New ChallengePaige Griffith, Jaroslaw Jedrych, Joel Sunshine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2017
Strategies for Increasing Pancreatic Tumor ImmunogenicityBurles A Johnson, Mark Yarchoan, Valerie Lee, et al.
Nature Reviews. Cancer|August 25, 2017
Targeting neoantigens to augment antitumour immunityMark Yarchoan, Burles A Johnson, Eric R Lutz, et al.
Nature Reviews. Cancer|February 25, 2017
Targeting neoantigens to augment antitumour immunityMark Yarchoan, Burles A Johnson, Eric R Lutz, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 19, 2021
Projected 30- day out-of-pocket costs and total spending on pancreatic enzyme replacement therapy under Medicare Part DArjun Gupta, Naveen Premnath, Ramy Sedhom, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2020
Intraductal pancreatic cancer is less responsive than cancer in the stroma to neoadjuvant chemotherapyKohei Fujikura, Danielle Hutchings, Alicia M Braxton, et al.
CA: a Cancer Journal for Clinicians|July 17, 2013
Recent progress in pancreatic cancerChristopher L Wolfgang, Joseph M Herman, Daniel A Laheru, et al.
Nuklearmedizin. Nuclear Medicine|April 17, 2025
Pancreatic Neuroendocrine Tumor incidentally found on 68Ga-PSMA PET/CTRodrigo Luna, Daniel A Laheru, Eun Ji Shin, et al.
Pancreas|December 28, 2020
Survival Outcomes of Adjuvant Chemotherapy Combined With Radiation Versus Chemotherapy Alone After Pancreatectomy for Distal Pancreatic Adenocarcinoma: A Single-Institution ExperienceBhavina Batukbhai, Joseph M Herman, Marianna Zahurak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression AnalysisArsen Osipov, Su Jin Lim, Aleksandra Popovic, et al.
Pageof 9